NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Brigade Hotel Ventures Sees Stable Growth Amidst Geopolitical Challenges

Brigade Hotel Ventures (BHVL) has reported a stable 6% RevPAR growth in Q4FY26, indicating a resilient performance by the hospitality sector. However, a 4% year-over-year decline in F&B revenue has limited total revenue growth to 2% YoY. The company's EBITDA margin was impacted by GST 2.0, leading to a 1.6% decline in EBITDA margin and a 4% YoY EBITDA decline.

Despite the challenges posed by geopolitical factors, which continue to weigh on foreign travel, BHVL's domestic guest share of over 70% could provide a cushion against the impact. The company has ambitious expansion plans, with the intention to develop nine new hotels with 1,700 keys across South India, requiring an estimated capital expenditure of approximately INR 36 billion over FY25-30.

Key Risks and Opportunities

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Our research team has identified key risks, including a potential fall in occupancies and delays in the execution of the company's expansion plans. Nevertheless, we maintain a BUY rating on BHVL, with a revised target price of INR 96, based on 16x Sep'27E EBITDA. This adjustment reflects a 6% cut to FY27/28E EBITDA due to geopolitical headwinds and a 6-12 month shift in capex timelines, resulting in lower net debt.

MetricQ4FY26Q4FY25Change
RevPAR Growth6%--
F&B Revenue Growth-4%--
Total Revenue Growth2%--
EBITDA Margin-1.6%--
EBITDA Decline4%--

We have revised our target price and recommendations to reflect the current market conditions and the company's growth prospects. Our outlook for BHVL remains positive, with a focus on its domestic guest share and ambitious expansion plans.

Investor Takeaway

Maintain BUY with a revised TP of INR 96 based on 16x Sep’27E EBITDA.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.